2023
DOI: 10.1016/j.cellsig.2023.110662
|View full text |Cite
|
Sign up to set email alerts
|

Epigenetic reactivation of PEG3 by EZH2 inhibitors suppresses renal clear cell carcinoma progress

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 30 publications
0
3
0
Order By: Relevance
“…Hypermethylation, considered an early event in renal cell carcinoma (RCC), correlates with tumor invasiveness [30]. Inhibiting EZH2 can reactivate PEG3, thereby inhibiting RCC progression [31]. Surgery is the primary treatment for RCC, and nephron-sparing surgery (NSS) is the preferred option to minimize peripheral lesions [30].…”
Section: Discussionmentioning
confidence: 99%
“…Hypermethylation, considered an early event in renal cell carcinoma (RCC), correlates with tumor invasiveness [30]. Inhibiting EZH2 can reactivate PEG3, thereby inhibiting RCC progression [31]. Surgery is the primary treatment for RCC, and nephron-sparing surgery (NSS) is the preferred option to minimize peripheral lesions [30].…”
Section: Discussionmentioning
confidence: 99%
“…It has been previously found, that the PEG3 expression is significantly reduced in renal clear cell carcinoma (ccRCC) compared to non-tumor renal tissue, and in vitro studies have shown that knockout of PEG3 causes acceleration of ccRCC proliferation. Findings suggest that PEG3 is indispensable for the regulation of ccRCC progression (Qiu et al, 2023). Another DEG associated with cancer revealed in BPA-treated tissues is Apolipoprotein A1 (APOA1).…”
Section: Discussionmentioning
confidence: 99%
“…That is, these pregnancy-specific stressors (e.g., financial distress) can be mutually exclusive from exposure to ACEs, exacerbating the association between ACEs and variable DNA methylation in infants. We specifically selected the imprinted genes PEG10/SGCE [ 29 , 30 ], NNAT , [ 31 , 32 ] IGF2 , [ 33 , 34 ] H19 [ 35 ], PLAGL1/HYMA1 , [ 36 ] PEG3 , [ 37 ] DLK1/MEG3, and MEG3-IG [ 38 , 39 ] for several reasons: 1) Perturbations in DNA methylation at these loci, particularly before germ layer specification, are stably transmitted during DNA replication to all subsequent lineages in the body throughout the life course [ 33 ]; 2) Imprinted genes are critically important to proper development and growth, and are known to be environmentally vulnerable to shifts in methylation [ 33 ]. Their importance is demonstrated by the fact that major abnormalities in imprinting are incompatible with life, while moderate abnormalities in imprinting are associated with a number of disorders and diseases, including cancer [ 34 ]; 3) DNA methylation profiles of imprinted genes are well documented; they are largely invariant across tissues, making it easier to identify deviations [ 38 ]; and 4) The DMRs of the above-mentioned genes chosen include four paternally methylated and four maternally methylated DMRs that contribute to establishment and/or maintenance of the imprinting status of 10 imprinted genes [ 29–39 ].…”
Section: Introductionmentioning
confidence: 99%